EQS-AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Werte in diesem Artikel
|
EQS Preliminary announcement financial reports: BRAIN Biotech AG
/ Preliminary announcement on the disclosure of financial statements
Werbung Werbung
BRAIN Biotech AG hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: January 15, 2025 Address: https://www.brain-biotech-group.com/de/investoren/finanzpublikationen-finanzkalender/finanzberichte/ Report Type: Annual financial report of the group Language: German Date of disclosure: January 15, 2025 Address: https://www.brain-biotech-group.com/de/investoren/finanzpublikationen-finanzkalender/finanzberichte/ Language: English Date of disclosure: January 15, 2025 Address: https://www.brain-biotech-group.com/en/investors/financial-publications-calendar/financial-reports/
07.01.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Werbung Werbung |
| Language: | English |
| Company: | BRAIN Biotech AG |
| Darmstädter Straße 34-36 | |
| 64673 Zwingenberg | |
| Germany | |
| Internet: | www.brain-biotech.com |
| End of News | EQS News Service |
|
|
2063065 07.01.2025 CET/CEST
Ausgewählte Hebelprodukte auf BRAIN Biotech
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf BRAIN Biotech
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu BRAIN Biotech AG
Analysen zu BRAIN Biotech AG
Keine Analysen gefunden.